We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$266M
AUM Growth
-$519M
Cap. Flow
-$520M
Cap. Flow %
-195.59%
Top 10 Hldgs %
24.71%
Holding
657
New
41
Increased
1
Reduced
224
Closed
243
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYCUW
176
Cycurion Inc Warrant
CYCUW
$267K
$43.2K 0.02%
485,584
-1,213
-0.2% -$95
REVB icon
177
Revelation Biosciences
REVB
$3.71M
$43.2K 0.02%
+6
New +$162K
MBAC.WS
178
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$42.3K 0.02%
384,364
-52,700
-12% -$5.08K
PNACR
179
DELISTED
Prime Number Acquisition I Corp. Right
PNACR
$42K 0.02%
250,000
BREZR
180
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$41.7K 0.02%
298,400
HUDAR
181
DELISTED
Hudson Acquisition I Corp. Right
HUDAR
$39.4K 0.01%
197,000
AXAC.RT
182
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Rights to receive one-tenth (1/10) of one Class A ordinary share
AXAC.RT
$38K 0.01%
200,000
ASCAR
183
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
$37K 0.01%
200,000
IMAQW
184
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$36K 0.01%
1,200,000
AISPW
185
Airship AI Holdings Warrants
AISPW
$12.5M
$35.5K 0.01%
236,832
-28,107
-11% -$2.32K
BWAQR
186
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$35K 0.01%
350,000
VHAQ.RT
187
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$35K 0.01%
700,000
NIOBW
188
NioCorp Developments Ltd Warrant
NIOBW
$52.9M
$32.4K 0.01%
+48,844
New +$36.1K
DMAQR
189
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$32.3K 0.01%
230,731
FGMCW
190
DELISTED
FG Merger Corp. Warrant
FGMCW
$31.3K 0.01%
447,460
-2,530
-0.6% -$212
MARXR
191
DELISTED
Mars Acquisition Corp. Rights
MARXR
$31K 0.01%
+155,000
New +$30.5K
CLINR
192
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$29.9K 0.01%
200,000
ASCBR
193
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$29.3K 0.01%
300,000
WINVR
194
DELISTED
WinVest Acquisition Corp. Right
WINVR
$28K 0.01%
299,800
JTAIW
195
DELISTED
Jet.AI Inc. Warrant
JTAIW
$27.8K 0.01%
423,739
-47,494
-10% -$2.33K
ARBEW icon
196
Arbe Robotics Warrant
ARBEW
$352K
$26.8K 0.01%
74,291
-114,311
-61% -$48.5K
GSRMR
197
DELISTED
GSR II Meteora Acquisition Corp. Right
GSRMR
$26.6K 0.01%
31,250
PPHPR
198
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$25.7K 0.01%
157,117
AIMDW icon
199
Ainos Warrants
AIMDW
$25K 0.01%
82,500
CDTTW
200
CDT Equity Inc Warrant
CDTTW
$1.56M
$24.5K 0.01%
272,504
-300
-0.1% -$23

Similar funds

CVI Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, CVI Holdings held 657 positions worth $266M, down 66% from $784M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CVI Holdings withdrew a net $520M in Q1 2023, closing 243 positions and reducing 224 holdings. Its most notable exit was ImmunityBio, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 64% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in GeneDx Holdings worth $3.56M.

  • CVI Holdings's largest Q1 2023 buy was GeneDx Holdings: 295,706 shares worth $3.56M.
  • CVI Holdings added most to TPG Pace Beneficial II Corp. in Q1 2023, an estimated $82.2K increase.
  • CVI Holdings's biggest Q1 2023 reduction was RTB Digital, cutting an estimated $1.96M.
  • CVI Holdings fully exited ImmunityBio in Q1 2023, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 25% of its $266M portfolio in Q1 2023.
  • CVI Holdings opened 41 new positions and closed 243 in Q1 2023.
  • CVI Holdings's portfolio value fell 66% quarter-over-quarter to $266M.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.